Dow Up 0.48% Nasdaq Up 0.43%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
11.79 0.06(0.51%) Aug 19, 4:00PM EDT
Prev Close:11.73
Open:11.74
Bid:11.30 x 1100
Ask:13.49 x 2000
1y Target Est:15.27
Beta:1.57
Earnings Date:Oct 23 - Oct 27 (Est.)
Day's Range:11.58 - 11.81
52wk Range:10.28 - 18.34
Volume:584,947
Avg Vol (3m):861,674
Market Cap:1.01B
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMGN

Comparison

Symbol% ChgMkt Cap
IMGNUp 0.51%1.01B
PFE183.50B
RHHBY248.97B
SGEN5.34B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.72
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its targeted antibody payload technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback